| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
39,596 |
29,018 |
$3.54M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,996 |
14,436 |
$1.07M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,967 |
1,959 |
$283K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,493 |
2,465 |
$245K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
411 |
258 |
$198K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,551 |
2,498 |
$130K |
| 93880 |
|
1,108 |
1,104 |
$124K |
| 87428 |
|
2,939 |
2,601 |
$120K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,128 |
1,118 |
$104K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
439 |
401 |
$87K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,065 |
3,554 |
$66K |
| 93000 |
|
5,292 |
5,231 |
$60K |
| 87631 |
|
862 |
832 |
$58K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,266 |
1,178 |
$47K |
| 99401 |
|
2,447 |
2,258 |
$41K |
| 95117 |
|
3,021 |
1,622 |
$31K |
| 87807 |
|
3,395 |
3,073 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,501 |
1,567 |
$28K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,601 |
4,122 |
$27K |
| 99051 |
|
4,905 |
4,250 |
$23K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
131 |
131 |
$16K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
139 |
138 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
306 |
294 |
$10K |
| 90686 |
|
538 |
536 |
$9K |
| 90674 |
|
330 |
328 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,129 |
1,088 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
443 |
440 |
$8K |
| 93015 |
|
160 |
160 |
$7K |
| 82947 |
|
2,305 |
1,881 |
$7K |
| 90670 |
|
36 |
36 |
$7K |
| 90688 |
|
432 |
431 |
$7K |
| 94010 |
|
310 |
291 |
$7K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
135 |
128 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
164 |
148 |
$6K |
| G0008 |
Administration of influenza virus vaccine |
645 |
645 |
$5K |
| 0064A |
|
131 |
129 |
$4K |
| 90677 |
|
13 |
13 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
834 |
783 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
6,672 |
6,416 |
$3K |
| 0011A |
|
98 |
98 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,192 |
1,117 |
$3K |
| 0012A |
|
63 |
63 |
$2K |
| 93351 |
|
14 |
14 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,183 |
989 |
$2K |
| 0002A |
|
54 |
54 |
$2K |
| 0001A |
|
50 |
50 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
195 |
184 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
225 |
209 |
$2K |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
369 |
365 |
$1K |
| 81002 |
|
684 |
656 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,048 |
985 |
$987.60 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
12 |
12 |
$967.90 |
| 92567 |
|
92 |
92 |
$961.87 |
| 90746 |
|
12 |
12 |
$827.25 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
16 |
16 |
$734.61 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
279 |
261 |
$637.49 |
| G0009 |
Administration of pneumococcal vaccine |
47 |
47 |
$468.83 |
| G9226 |
Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) |
30 |
25 |
$262.50 |
| 99173 |
|
131 |
130 |
$225.46 |
| 99406 |
|
13 |
12 |
$152.31 |
| 86308 |
|
25 |
25 |
$91.03 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13 |
12 |
$85.00 |
| 83014 |
|
112 |
111 |
$44.36 |
| 99072 |
|
193 |
162 |
$33.24 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
146 |
133 |
$5.59 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
20 |
20 |
$1.92 |
| 91306 |
|
111 |
111 |
$0.06 |
| 91300 |
|
95 |
79 |
$0.00 |
| 91301 |
|
206 |
198 |
$0.00 |
| 91307 |
|
15 |
15 |
$0.00 |